Potassium clavulanate mixture with silicon dioxide (1:1) Catalog No.:M17525-C InChi: InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8

InChi: InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8

5S)-1-(benzenesulfonyl)-5-[[(1S)-1-carboxy-2-[4-(pyrrolidine-1-carbonyloxy)phenyl]ethyl]carbamoyl]pyrrolidin-3-yl]triazol-4-yl]methylsulfamoyl]-2-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]benzenesulfonate

blocks the formation of pathological aggregates of prion protein (PrPSc) and of α-synuclein (α-syn)

Sephin1 was orally dosed to MPZmutant mice or SOD1mutant mice at 1 mg/Kg twice a day

ALK4 and ALK7

Potassium clavulanate mixture with silicon dioxide (1:1) Catalog No.:M17525-C InChi: InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8Potassium clavulanate mixture with silicon dioxide (1: 1) is a powdered mixture of 1 part Potassium clavulanate to 1 part Silicon dioxide. Product information Molecular Weight: 297. 34 Formula: C8H8KNO7Si Chemical Name: potassium; dioxosilane;(2R, 3Z, 5R) 3 (2 hydroxyethylidene) 7 oxo 4 oxa 1 azabicyclo[3. 2. 0]heptane 2 carboxylate Smiles: [K+].[O ]C(=O)[C@H]1 C(=C CO) O[C@@H]2CC(=O)N12. O=[Si]=O InChiKey: IKLCKTBOBQJLLS ZOBQOELFSA M InChi: InChI=1S